GC15779
Cabozantinib
Also listed as Cabozantinib (XL184, BMS-907351)
Cabozantinib (XL184,BMS-907351) is a novel MET and VEGFR2 inhibitor that simultaneously inhibits metastasis, angiogenesis and tumor growth
ChemicalCAS849217-68-1MW501.51FormulaC28H24FN3O5
- CAS number
- 849217-68-1
- Molecular weight
- 501.51
- Formula
- C28H24FN3O5
- Solubility
- ≥ 25·1mg/mL in DMSO
- InChIKey
- ONIQOQHATWINJY-UHFFFAOYSA-N
- Catalogue number
- GC15779
- Brand
- GLPBIO
Computed properties PubChem CID 25102847 · XLogP 5.4 · TPSA 98.8 Ų · H-bond donors 2
- XLogP
- 5.4
- TPSA
- 98.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Rotatable bonds
- 8
- Heavy atoms
- 37
SMILES COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
Computed descriptors from PubChem (CID 25102847), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il